Imatinib for bleomycin induced pulmonary toxicity: a case report and evidence‐base review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Imatinib for bleomycin induced pulmonary toxicity: a case report and evidence‐base review

Published:2016-04 Issue:5 Volume:4 Page:486-490
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Banakh Iouri¹,Lam Alice¹,Tiruvoipati Ravindranath²³,Carney Ian²³,Botha John²³

Affiliation:

1. Department of Pharmacy Frankston Hospital Peninsula Health Frankston Vic. Australia

2. Department of Intensive Care Medicine Frankston Hospital Frankston Vic. 3199 Australia

3. School of Public Health Faculty of Medicine, Nursing and Health Sciences Monash University Clayton Vic. 3800 Australia

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.549

Reference19 articles.

1. Bleomycin-Induced Pneumonitis

2. Incidence, outcome and predictors of bleomycin pulmonary toxicity in a university hospital in Oman

3. American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects

4. Bleomycin-Induced Lung Injury

5. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nintedanib Treatment in a Child with Pulmonary Fibrosis;Turkish Journal of Pediatric Disease;2023-09-13

2. Anti‐SARS‐CoV‐2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID‐19 therapy;Journal of Medical Virology;2022-09-28

3. Frequency and risk factors of bleomycin-induced pulmonary toxicity in South Indian patients with germ-cell tumors;Journal of Cancer Research and Therapeutics;2021

4. Imatinib Treatment for Bleomycin-Induced Pulmonary Toxicity;Turkish Thoracic Journal;2020-12-10

5. Repurposing of Kinase Inhibitors for Treatment of COVID-19;Pharmaceutical Research;2020-08-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3